Showing results (1521-1530 of 2,182) with videos related to

Sort By:
Pageof 219
Journal of Medical Imaging (Bellingham, Wash.)|February 5, 2019
Impact of prevalence and case distribution in lab-based diagnostic imaging studiesBrandon D Gallas, Weijie Chen, Elodia Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabineS B Murphy, W P Bowman, M Abromowitch, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 18, 2022
Large Room Temperature Anomalous Transverse Thermoelectric Effect in Kagome Antiferromagnet YMn6 Sn6Subhajit Roychowdhury, Andrew M Ochs, Satya N Guin, et al.
Annals of Hematology|May 26, 2022
Oncology stewardship in acute myeloid leukemiaMadeleine A Ochs, Bernard L Marini, Anthony J Perissinotti, et al.
BMC Genomics|May 3, 2012
Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinomaElana J Fertig, Qing Ren, Haixia Cheng, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174Christopher M Bearden, Avinash Agarwal, Benita K Book, et al.
Journal of Biological Response Modifiers|December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancerS A Sherwin, K A Foon, P G Abrams, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administrationJ A Knost, S A Sherwin, P G Abrams, et al.
Respiratory Research|October 5, 2007
Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient miceLars Knudsen, Matthias Ochs, Rosemarie Mackay, et al.
Journal of Neuroimmunology|October 5, 2013
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant gliomaKatharina Ochs, Felix Sahm, Christiane A Opitz, et al.
Pageof 219